These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21306363)

  • 41. Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H; Bornstein SS;
    Ann Intern Med; 2019 Dec; 171(11):825-827. PubMed ID: 31711137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prescription drug access: not just a Medicare problem.
    Cunningham PJ
    Issue Brief Cent Stud Health Syst Change; 2002 Apr; (51):1-4. PubMed ID: 11977267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Copayments for prescription medicines on a public health insurance scheme in Ireland.
    Sinnott SJ; Normand C; Byrne S; Woods N; Whelton H
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):695-704. PubMed ID: 26696242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient liability, treatment adherence, and treatment persistence associated with state bans of copay accumulator adjustment programs.
    Patel A; Sheinson D; Wong WB
    J Manag Care Spec Pharm; 2024 Sep; 30(9):909-916. PubMed ID: 39213141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.
    Lu CY; Law MR; Soumerai SB; Graves AJ; LeCates RF; Zhang F; Ross-Degnan D; Adams AS
    Clin Ther; 2011 Jan; 33(1):135-44. PubMed ID: 21397779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased Use Of Prescription Drugs Reduces Medical Costs In Medicaid Populations.
    Roebuck MC; Dougherty JS; Kaestner R; Miller LM
    Health Aff (Millwood); 2015 Sep; 34(9):1586-93. PubMed ID: 26355062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The differential impact of copayment on drug use in a Medicaid population.
    Reeder CE; Nelson AA
    Inquiry; 1985; 22(4):396-403. PubMed ID: 2934334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA; Rogowski J; Kington R
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.
    Bishop CE; Ryan AM; Gilden DM; Kubisiak J; Thomas CP
    Health Serv Res; 2009 Jun; 44(3):1010-28. PubMed ID: 19291168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Copayments for Medications in 2015. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2015 Sep; 80(179):55544-5. PubMed ID: 26387152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Full coverage for preventive medications after myocardial infarction.
    Choudhry NK; Avorn J; Glynn RJ; Antman EM; Schneeweiss S; Toscano M; Reisman L; Fernandes J; Spettell C; Lee JL; Levin R; Brennan T; Shrank WH;
    N Engl J Med; 2011 Dec; 365(22):2088-97. PubMed ID: 22080794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs.
    Stroupe KT; Smith BM; Lee TA; Tarlov E; Durazo-Arvizu R; Huo Z; Barnett T; Cao L; Burk M; Cunningham F; Hynes DM; Weiss KB
    Med Care; 2007 Nov; 45(11):1090-7. PubMed ID: 18049350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
    Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incentive formularies and changes in prescription drug spending.
    Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study.
    Rome BN; Gagne JJ; Avorn J; Kesselheim AS
    Am Heart J; 2021 Mar; 233():109-121. PubMed ID: 33358690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health savings accounts and health care spending.
    Lo Sasso AT; Shah M; Frogner BK
    Health Serv Res; 2010 Aug; 45(4):1041-60. PubMed ID: 20528988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
    Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
    Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.